The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin. [electronic resource]
Producer: 20190128Description: 59 p. digitalISSN:- 1475-2840
- Animals
- Cardiovascular Diseases -- drug therapy
- Comorbidity
- Diabetes Mellitus, Type 2 -- drug therapy
- Diabetic Angiopathies -- drug therapy
- Dipeptidyl Peptidase 4 -- metabolism
- Dipeptidyl-Peptidase IV Inhibitors -- adverse effects
- Humans
- Linagliptin -- adverse effects
- Risk Factors
- Signal Transduction -- drug effects
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.